Specifically, spironolactone-dependent reduction of TRPC1 in atheroma was strongly associated with a marked decrease of atherosclerosis, whereas spironolactone-dependent downregulation of medial TRPC6 was associated with decreased histamine-induced contractility and reduced [Ca2+]i transients in the medial layer. Here, TRPC6 is linked to atherosclerosis.